PF : Analysis & Opinions

  • Showing 1-100 of 261 items
  • 1
  • 2
  • 3
  • >>
  1. Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst ...

    December 18, 2014
    Pfizer (PFE) has moved its experimental Duchenne muscular dystrophy treatment into a phase II study.
  2. Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst ...

    December 18, 2014
    Shares of Halozyme (HALO) jumped after announcing a worldwide collaboration and license agreement with Johnson & Johnson ...
  3. 5 Real Estate Mutual Funds for Steady Returns - Mutual Fund ...

    December 18, 2014
    Real Estate mutual funds offer a convenient method to invest in real estate because of low initial investment requirements ...
  4. Jacobs Drives Organic Growth on Award-Winning Contract - Analyst ...

    December 17, 2014
    Jacobs Engineering Group Inc. (JEC) recently received the Facility of the Year Award (FOYA) for successfully delivering the ...
  5. OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst ...

    December 17, 2014
    OncoGenex Pharmaceuticals, Inc. (OGXI) has completed enrolling patients in its phase II Rainier study on apatorsen for previously ...
  6. Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics ...

    December 16, 2014
    Baxter International Inc (BAX) is set to divest its Vero cell technology and related assets to Nanotherapeutics, Inc for ...
  7. Talisman Energy Soars on $13 Billion Acquisition by Repsol - ...

    December 16, 2014
    Shares of Talisman Energy (TLM) jumped nearly 47% in the pre-market trading session following its confirmation of being acquired ...
  8. Will Westamerica's Revenue Concerns Abate in Near Term? - Analyst ...

    December 16, 2014
    While prudent expense management continued to be a positive, pressure on revenue growth remained a major concern for Westamerica ...
  9. Talisman Energy Soars on Speculation of Repsol Takeover - Analyst ...

    December 15, 2014
    Shares of Talisman Energy Inc. (TLM) gained over 16% following speculations that the Spanish oil firm, Repsol S.A. (REPYY) ...
  10. Bumpy Road Ahead for U.S. Banks: Stay Away? - Industry Outlook

    December 3, 2014
    Bumpy Road Ahead for U.S. Banks: Stay Away? - Industry Outlook
  11. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  12. 9 Widely Overlooked Small Banks That Offer Big Profit Potential

    November 18, 2014
    Last week we talked about riding the coat tails of bank stock activists to earn out sized profits in the stock market. A ...
  13. Get Ready for Shift in Fed Policy - Ahead of Wall Street

    October 28, 2014
    The Fed genuinely wants to get out of the QE business and start the monetary policy 'normalization' process.
  14. Profit From The Largest Generation In History: 2 Companies Boomers ...

    October 8, 2014
    Geo-political tensions, historic monetary programs and a global economy that has yet to show us much have all helped to quiet ...
  15. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  16. An Investing Legend Predicts A Major M&A Boom -- Here's How To ...

    August 7, 2014
    Some high-profile buyout deals have been falling apart lately. For instance, the third largest U.S. wireless carrier Sprint ...
  17. Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little blue pill.

    Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  18. Q3 Estimates Beginning to Slip - Ahead of Wall Street

    July 29, 2014
    Lower revisions to the magnitude of Q3 estimates will still be a net positive -- we will see how this trend unfolds.
  19. Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry ...

    July 24, 2014
    Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
  20. Can Consumer Staples Rebound? - Industry Outlook

    June 10, 2014
    Can Consumer Staples Rebound? - Industry Outlook
  21. How Can the Market Build from Here? - Ahead of Wall Street

    June 9, 2014
    The broad stock market indexes finished at new all-time highs on Friday after the strong jobs report.
  22. What Will Businesses Spend On? - Ahead of Wall Street

    May 27, 2014
    Pilgrim Pride (PPC) is now acquiring Hillshire (HSH) for roughly $5.5B following Hillshire's plans to buy out Pinnacle Foods ...
  23. #PreMarket Primer: Tuesday, May 27: Hope Rises In Ukraine Despite ...

    May 27, 2014
    Following the election of billionaire Petro Poroshenko as President of Ukraine, diplomatic tensions seemed to be easing ...
  24. Global Markets Indicate Weakness - Ahead of Wall Street

    May 19, 2014
    Pre-open sentiment is pointing to a weak start for U.S. stocks, with soft overnight trading action across global markets.
  25. #PreMarket Primer: Monday, May 19: DirecTV Rises On Offer From ...

    May 19, 2014
    AT&T Inc. announced a deal to acquire DirecTV for $49 billion over the weekend, as the firm attempts to adapt to a quickly ...
  26. A Big Week for Economic & Earnings Data - Ahead of Wall Street

    April 28, 2014
    The week is packed with economic and Q1 earnings reports.
  27. New Brunswick, N.J.-based Johnson & Johnson is probably most famous as the parent company of multiple household products that double as household names.

    How Johnson & Johnson Became A Household Name

    April 21, 2014
    New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household ...
  28. Hedge Funds Love These 3 Pharma Stocks

    April 14, 2014
    In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks. For 2 ...
  29. U.S. Banks Stock Outlook - Apr 2014 - Industry Outlook

    April 8, 2014
    U.S. Banks Stock Outlook - Apr 2014 - Industry Outlook
  30. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  31. Consumer Staples Stock Outlook - Feb 2014 - Industry Outlook

    February 18, 2014
    Consumer Staples Stock Outlook - Feb 2014 - Industry Outlook
  32. These Companies Know The Future Before It Happens

    February 13, 2014
    Wouldn't it be great to have a crystal ball to see into the future?You could know when the next market crash will be, ...
  33. Buybacks Instead of Capital Investment - Ahead of Wall Street

    January 28, 2014
    Hard to make sense of the fact that companies would consider it prudent to invest in their own sharesinstead of their businesses.
  34. For investors, betting on Latin America’s rising free-market superstars could be the best way to play the region in a portfolio.

    Playing The Latin American Divide

    January 14, 2014
    While investors tend to lump all of Latin America together into one cohesive unit, the truth is there is a pretty big divide ...
  35. Capital Spending vs. Buybacks - Ahead of Wall Street

    December 24, 2013
    If the Durable Goods report is a sign of things to come, then it would be a material improvement in the economic outlook.
  36. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  37. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  38. Convertible bonds are a perfect way to potentially hedge the downside risk as well as play the upside from continued swooning markets.

    The Convertible Way To Play This Market

    November 8, 2013
    Investors are certainly facing a quandary. The broad market has gone up by leaps and bounds since the end of the recession. ...
  39. Will Google Glass Be Dethroned Ahead Of Its Release? (GOOG)

    September 5, 2013
    Google (NASDAQ: GOOG) gained some attention this week after reports claimed that the company will launch a separate app store ...
  40. Short Sellers Increase Stakes in Toll Bros., M/I Homes (MHO, ...

    August 28, 2013
    The short interest moves in residential construction stocks were mixed again during the early weeks of August, as concerns ...
  41. History Suggests Street Will Get Over “Disappointing” Smucker ...

    August 21, 2013
    Smucker isn't cheap, but worries about K-Cup growth seem a little overdone.
  42. Better Margins Can't Hide Merck's Growth Challenges

    July 30, 2013
    Merck's near-term growth is looking weak, but margin improvements and an underestimated pipeline could offer upside.
  43. Pfizer Looking A Little Tired

    July 30, 2013
    Pfizer gets a boost from better margins, but the growth outlook is pretty feeble.
  44. Wall Street Happy To Hum La AbbVie En Rose

    July 26, 2013
    AbbVie's pipeline is better than some think, but valuation is no particular bargain right now.
  45. Weak Earnings Growth Outside Finance - Earnings Trends

    July 25, 2013
    Weak Earnings Growth Outside Finance - Earnings Trends
  46. Watch Out For Monthly Dividend ETFs

    July 23, 2013
    Dividend investing has been a major theme in the ETF world for several years as investors have escaped near zero interest ...
  47. Drugs Driving JNJ, With Slow Progress In Devices And Consumer

    July 17, 2013
    JNJ is getting great performance out of its drug business, but the remainder still lags.
  48. 3 Things You Need To Know About Preferred Stock ETFs

    July 12, 2013
    Preferred stocks are just one popular market segment accessible through ETFs. Almost every corner of the global financial ...
  49. FDA Accepts Pfizer sNDA - Analyst Blog

    June 26, 2013
    The FDA's decision regarding the Xeljanz label expansion should be out by Feb 2014.
  50. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  51. Pfizer Gives Up Stake in Zoetis - Analyst Blog

    June 25, 2013
    Pfizer lowered its outlook for 2013 to reflect the impact of the divestment of the remaining stake in Zoetis.
  52. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  53. Ariad's Iclusig in GIST Phase II Study - Analyst Blog

    June 18, 2013
    The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase inhibitor ...
  54. Sallie Mae Suspends Credit Facility - Analyst Blog

    June 11, 2013
    Sallie Mae, declared the closure of a $6.8 billion credit facility, which used to aid term securitization of its federally ...
  55. Make Money From Spinoffs

    June 4, 2013
    According to Barrons, 15 spinoffs have taken place in 2013 through the end of May, 50% more than last year. It seems all ...
  56. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  57. Coty Readies IPO

    May 28, 2013
    Fragrance maker Coty filed a registration statement amendment May 28 that sees it raising as much as $1.2 billion from its ...
  58. After A Big Rally, Pfizer Might Need Some Rest

    May 21, 2013
    A big rally has brought Pfizer back to fair value.
  59. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  60. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  61. Pinnacle Foods Gains 11% In IPO Debut--Now What?

    April 2, 2013
    Blackstone Group brought Pinnacle Foods (NYSE:PF) to market March 28. The maker of Vlasic pickles and other well known brands ...
  62. Visual Guide To Investing In Preferred Stock ETFs

    March 14, 2013
    Preferred stock ETFs have become a big hit with some investors. Find out why!
  63. Steady Progress And Unappreciated Value At MetLife

    February 18, 2013
    MetLife is still making steady improvements, but the stock doesn't reflect it.
  64. Agilent Misses, Guidance Disappoints - Analyst Blog

    February 15, 2013
    Agilent Technologies' A) fiscal first quarter earnings per share of 63 cents missed the Zacks Consensus Estimate by 4 cents, ...
  65. Inside First Trust's New Preferred Securities ETF (FPE) - ETF ...

    February 14, 2013
    Although markets continue to perform well, income-paying choices remain favorites of many investors. Considering that many ...
  66. MedTech Industry Stock Outlook - Jan 2013 - Zacks Analyst Interviews

    January 29, 2013
    We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide ...
  67. Pfizer Readies Zoetis For Market

    January 23, 2013
    Pfizer filed further details about its tentative spin-off of Zoetis, its animal health business.
  68. Data on Novartis' Afinitor - Analyst Blog

    January 14, 2013
    As per recent data published in The Lancet, Novartis' (NVS) cancer drug, Afinitor (everolimus), helped reduce the tumor size ...
  69. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust pipeline. The ...
  70. A Look Back At The Year In Pharmaceuticals

    December 28, 2012
    Pharmaceuticals have had a decidedly mixed year in 2012, largely on the basis of the revenue growth outlook.
  71. Bridge Capital: A Strong Buy - Analyst Blog

    December 26, 2012
    Rising earnings estimates on the back of solid third quarter results - including a 38.1% earnings surprise - helped Bridge ...
  72. U.S. Banks Stock Outlook - Dec 2012 - Zacks Analyst Interviews

    December 18, 2012
    What's in Store for U.S. Banks in 2013? U.S. banks look ready for 2013 with uninterrupted expense control, sound balance ...
  73. 101 High Yielding ETFs For Every Dividend Investor

    December 6, 2012
    With interest expected to stay at near-zero levels for the foreseeable future, many investors have found it challenging to ...
  74. BASF's Deal For Pronova Shows The Importance Of Good Nutrition

    November 23, 2012
    BASF ties up another high-grade fish oil company in Pronovna, adding to the recent rise in popularity for the fish oil space. ...
  75. Pfizer's Lyrica Scores in Study - Analyst Blog

    November 21, 2012
    Pfizer Inc. (PFE) recently announced positive top-line data on its once-daily formulation of Lyrica (pregabalin). Results ...
  76. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  77. Bayer Buys Schiff Nutrition International: Winners All Around

    November 7, 2012
    Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
  78. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  79. Pfizer's Third Quarter Earnings Report

    November 1, 2012
    Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global pharmaceutical ...
  80. Principal Lags EPS Est, Beats Revs - Analyst Blog

    October 26, 2012
    Principal Financial Group, Inc. (PFG) reported third quarter 2012 operating earnings of 45 cents per share, lagging the Zacks ...
  81. Pfizer Third Quarter Earnings Preview

    October 25, 2012
    When Pfizer (NYSE:PFE) releases its third quarter earnings on Tuesday, October 30, 2012, analysts are expecting a 16.1% drop ...
  82. RAFI ETFs YTD: Boom Or Bust?

    October 24, 2012
    As the ETF industry continues to develop, many investors have begun to move away from the more “traditional” funds in favor ...
  83. Drugs Have Moved J&J On To A New Phase

    October 17, 2012
    J&J is back on a growth track, but the device business needs fixing.
  84. Ultimate Guide To S&P U.S. Preferred Stock Fund (PFF)

    October 17, 2012
    Preferred stock investing just isn’t what it used to be. Once a relatively common way for companies to raise money, the expansion ...
  85. For Jabil, The Price Is Right, But The Timing Is Uncertain

    September 27, 2012
    Jabil's value looks appealing, but the end markets are shaky and the industry is brutal. If investors believe in the new ...
  86. Pfizer Is Near a Key Resistance Area

    September 27, 2012
    New York, September 27th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading very close to calculated resistance ...
  87. Principal's Notes Rated by Fitch - Analyst Blog

    September 21, 2012
    Fitch Ratings conferred 'A-' rating to the latest notes issued by Principal Financial Group, Inc. (PFG), as per Reuters. ...
  88. Are Preferred Stock ETFs Worth the Risk? - ETF News And Commentary

    September 4, 2012
    In the current environment of ultra-low interest rates, the yield-hungry investors seek higher income from non-traditional ...
  89. ETFs For Consistent Dividend Payers

    August 28, 2012
    The global economic slowdown has certainly affected how investors choose to allocate their assets, as many sectors of the ...
  90. Profiling 5 Corporate Bond ETFs Besides LQD

    August 21, 2012
    When it comes to corporate bond ETFs, there is no fund more popular than iShares’ infamous iBoxx $ Investment Grade Corporate ...
  91. Canada ETFs: 9 Ways To Play

    August 21, 2012
    When it comes to diversifying your portfolio, many investors often overlook the dynamic economy of our Northern neighbor. ...
  92. Pfizer Looks To Spin Off Animal Health Unit

    August 15, 2012
    Pfizer has filed plans to sell up to 20% of its animal-health unit in the first half of 2013 to focus on human pharmaceuticals. ...
  93. The Week Ahead In Healthcare

    August 13, 2012
    The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit, likely in part because Johnson & ...
  94. Preferred Stock ETFs Explained - Exchange Traded Fund (ETF)

    August 1, 2012
    Eric Dutram takes a closer look at the preferred stock ETF market and two new funds that recently hit the space including: ...
  95. Huntington Launches Sector Rotation ETF (HUSE)

    July 30, 2012
    Huntington, fresh off its initial foray into the ETF industry in June, has doubled the size of its lineup with the launch ...
  96. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take profits on ...
  97. 4 Dividend ETFs With Higher Yields Than LQD

    July 24, 2012
    Once upon a time, the conventional wisdom was that investors should hold stocks as a source of long-term capital appreciation ...
  98. Is Pfizer Reversing?

    July 23, 2012
    New York, July 23rd (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) closed the trading day lower by $0.1 or -0.4% ...
  99. Market Vectors Debuts Preferred ex Financials ETF (PRXF) - ETF ...

    July 17, 2012
    Market Vectors, the ETF brand from investment company Van Eck, has announced the latest addition to its lineup, the Preferred ...
  100. The Most Overbought Dow Stocks

    July 3, 2012
    Despite large first-quarter gains, two big Dow stocks show strong monthly chart formations and are worthy of new buying. ...
  • Showing 1-100 of 261 items
  • 1
  • 2
  • 3
  • >>
Trading Center